- The study investigated the long-term efficacy and mechanisms of continuous theta-burst stimulation (cTBS) for alcohol use disorder.
- Fifty-five alcohol-dependent patients were randomized to receive 20 sessions of active or sham cTBS targeting the right dorsolateral prefrontal cortex.
- Active cTBS significantly reduced the risk of returning to baseline-or-higher drinking over 12 months (HR = 0.488, 95% CI [0.245, 0.971]).
- The authors concluded that cTBS offers long-term clinical efficacy by modulating craving-related neural networks and gene expression linked to synaptic transmission.
- This suggests cTBS as a circuit-based therapy for addiction, warranting consideration for managing alcohol use disorder.
Targeting Alcohol Use Disorder: The Evolving Role of Neuromodulation
Alcohol use disorder (AUD) remains a significant public health challenge, characterized by high rates of relapse despite available pharmacological and behavioral interventions [1, 2]. The chronic nature of AUD highlights a need for treatments that produce durable effects by addressing the underlying neurobiology of craving [3]. Non-invasive brain stimulation techniques, such as transcranial magnetic stimulation, have shown an ability to modulate craving and alcohol use in the short term [4, 3, 5]. However, questions regarding the long-term clinical efficacy and the precise neural mechanisms of these interventions have persisted, limiting their widespread adoption [6, 7]. A recent study sought to address these gaps by evaluating the durability of one such technique, continuous theta-burst stimulation (cTBS), over 12 months and mapping its effects on brain circuitry.
Sustained Reduction in Drinking: A 12-Month Follow-Up
To assess the long-term impact of neuromodulation on drinking behavior, a randomized controlled trial was conducted with 55 patients diagnosed with alcohol dependence. Participants were assigned to receive either active continuous theta-burst stimulation (cTBS) targeting the right dorsolateral prefrontal cortex (DLPFC), a region implicated in executive control and craving, or a sham cTBS procedure. The treatment protocol consisted of 20 sessions delivered over a two-week period. Clinical outcomes were then tracked across five follow-up assessments spanning 12 months. The study found that active cTBS was associated with a substantially lower risk of relapse. Specifically, patients in the active treatment group had a more than 50% reduction in the risk of returning to baseline-or-higher levels of drinking over the 12-month follow-up period (HR = 0.488, 95% CI [0.245, 0.971]). Additionally, at the end of the two-week treatment phase, significant group-by-time interactions were observed for both Alcohol Use Disorders Identification Test (AUDIT) scores and subjective craving scores, indicating a treatment-specific reduction in symptom severity and craving that was not seen in the sham group.
Unpacking the Neural Circuitry of Craving Modulation
Beyond the clinical outcomes, the researchers investigated the neuroplastic changes underlying the treatment's effect. Using a functional MRI (fMRI) cue-reactivity task, where patients viewed alcohol-related images to provoke craving, the study mapped the associated brain network activity. The analysis identified a distinct craving-related network signature. This signature was defined by two key patterns: hyperconnectivity between the frontoparietal network, which is critical for cognitive control, and subcortical networks central to reward processing, alongside hypoconnectivity between the brain's visual and ventral attention systems, which are involved in orienting to salient environmental cues. This suggests that in the context of craving, communication is heightened between control and reward circuits while it is dampened in circuits that process external visual information. Critically, the investigators found that the magnitude of change in the connectivity strength of this network correlated with both immediate and long-term reductions in drinking, directly linking the modulation of this specific brain circuit to the observed clinical improvement.
Molecular Underpinnings: Genes Linked to Network Modulation
To understand the biological basis of these circuit-level changes, the study explored the molecular pathways involved. The researchers employed transcriptome association analysis, a computational technique that correlates the spatial map of a brain network with large-scale data on gene expression across the brain. This analysis revealed that the identified craving-network pattern was spatially associated with genes enriched for two fundamental neurobiological processes: synaptic transmission and myelination. The link to synaptic transmission suggests that cTBS may exert its therapeutic effect by directly altering the efficiency of neuronal communication within the craving circuit. The association with myelination, the process that insulates nerve fibers to speed up signal conduction, implies that the treatment may also induce structural plasticity, potentially strengthening the physical pathways that support improved cognitive control over addictive behaviors. These findings provide multiscale evidence, from clinical behavior down to gene expression, for the mechanisms by which cTBS may achieve a durable reduction in alcohol consumption.
References
1. Fehring DJ, Morrison-Ham J, Cobden AL, et al. Trialing addiction neurocircuitry targets and directionality of brain stimulation effects: A deep TMS/fMRI trial in people with alcohol use disorder.. Contemporary clinical trials communications. 2025. doi:10.1016/j.conctc.2025.101515
2. Trojak B, Soudry‐Faure A, Abello N, et al. Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial. Trials. 2016. doi:10.1186/s13063-016-1363-8
3. Mehta D, Praecht A, Ward HB, et al. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacology. 2023. doi:10.1038/s41386-023-01776-0
4. Hyde J, Carr H, Kelley NJ, et al. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials. Molecular Psychiatry. 2022. doi:10.1038/s41380-022-01524-8
5. Bormann NL, Oesterle T, Arndt S, Karpyak VM, Croarkin PE. Systematic review and meta‐analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders. American Journal on Addictions. 2024. doi:10.1111/ajad.13517
6. Belgers M, Eijndhoven PV, Markus W, Schene AH, Schellekens A. rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial. Journal of Clinical Medicine. 2022. doi:10.3390/jcm11040951
7. Durazzo T, Kraybill EP, Stephens LH, et al. Intermittent theta burst to the left dorsolateral prefrontal cortex promoted decreased alcohol consumption and improved outcomes in those with alcohol use disorder: A randomized, double-blind, placebo-controlled clinical trial.. Drug and Alcohol Dependence. 2025. doi:10.1016/j.drugalcdep.2025.112641